Skip to Main Content

Author Details

Haley B Naik
University of California San Francisco
2000
92
21
PMIDPaper TitleJournal TitlePublished Year
37976235Global consensus process to establish a core dataset for hidradenitis suppurativa registries.Br J Dermatol2024
37823362Longitudinal remote monitoring of hidradenitis suppurativa: a pilot study.Br J Dermatol2024
37976235Global consensus process to establish a core dataset for hidradenitis suppurativa registries.Br J Dermatol2024
37823362Longitudinal remote monitoring of hidradenitis suppurativa: a pilot study.Br J Dermatol2024
36252715A Practical Guide for Primary Care Providers on Timely Diagnosis and Comprehensive Care Strategies for Hidradenitis Suppurativa.Am J Med2023
36370903Reply-Response to Anakinra for refractory pustular psoriasis: A phase II, open label, dose-escalation trial.J Am Acad Dermatol2023
36396891Hidradenitis suppurativa and sleep: a systematic review.Arch Dermatol Res2023
36252715A Practical Guide for Primary Care Providers on Timely Diagnosis and Comprehensive Care Strategies for Hidradenitis Suppurativa.Am J Med2023
37755725Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement.JAMA Dermatol2023
37927367Female sex and younger age are associated with hidradenitis suppurativa diagnostic delay.Int J Womens Dermatol2023
36585607Real-World Findings on the Characteristics and Treatment Exposures of Patients with Hidradenitis Suppurativa from US Claims Data.Dermatol Ther (Heidelb)2023
37210215Patient-reported influences on COVID-19 vaccine acceptance and hesitancy in people with hidradenitis suppurativa.Br J Dermatol2023
37276155Increased Doses of Adalimumab are Associated With Clinical Improvement of Hidradenitis Suppurativa.J Drugs Dermatol2023
36891871Factors associated with disease-specific life impact in patients with hidradenitis suppurativa: results from the Global VOICE project.Br J Dermatol2023
36824918Tertiary Lymphoid Structures Sustain Cutaneous B cell Activity in Hidradenitis Suppurativa.bioRxiv2023
37017984Patient Perspectives of Health System Barriers to Accessing Care for Hidradenitis Suppurativa: A Qualitative Study.JAMA Dermatol2023
36566748Biologic Therapy Is Not Associated with Increased COVID-19 Severity in Patients with Hidradenitis Suppurativa: Updated Findings from the Global Hidradenitis Suppurativa COVID-19 Registry.Dermatology2023
37099321The Critical Need for Reliable and Clinically Meaningful Outcome Measures for Hidradenitis Suppurativa.JAMA Dermatol2023
37755725Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement.JAMA Dermatol2023
37927367Female sex and younger age are associated with hidradenitis suppurativa diagnostic delay.Int J Womens Dermatol2023
37017984Patient Perspectives of Health System Barriers to Accessing Care for Hidradenitis Suppurativa: A Qualitative Study.JAMA Dermatol2023
37210215Patient-reported influences on COVID-19 vaccine acceptance and hesitancy in people with hidradenitis suppurativa.Br J Dermatol2023
37276155Increased Doses of Adalimumab are Associated With Clinical Improvement of Hidradenitis Suppurativa.J Drugs Dermatol2023
37099321The Critical Need for Reliable and Clinically Meaningful Outcome Measures for Hidradenitis Suppurativa.JAMA Dermatol2023
36585607Real-World Findings on the Characteristics and Treatment Exposures of Patients with Hidradenitis Suppurativa from US Claims Data.Dermatol Ther (Heidelb)2023
36396891Hidradenitis suppurativa and sleep: a systematic review.Arch Dermatol Res2023
36566748Biologic Therapy Is Not Associated with Increased COVID-19 Severity in Patients with Hidradenitis Suppurativa: Updated Findings from the Global Hidradenitis Suppurativa COVID-19 Registry.Dermatology2023
36824918Tertiary Lymphoid Structures Sustain Cutaneous B cell Activity in Hidradenitis Suppurativa.bioRxiv2023
36891871Factors associated with disease-specific life impact in patients with hidradenitis suppurativa: results from the Global VOICE project.Br J Dermatol2023
36370903Reply-Response to Anakinra for refractory pustular psoriasis: A phase II, open label, dose-escalation trial.J Am Acad Dermatol2023
34537252Biologic therapy is not associated with increased COVID-19 severity in patients with hidradenitis suppurativa: Initial findings from the Global Hidradenitis Suppurativa COVID-19 Registry.J Am Acad Dermatol2022
36287577Evaluation of Hidradenitis Suppurativa Diagnostic Criteria in Pediatric Patients.JAMA Dermatol2022
36278491Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-α therapy.JCI Insight2022
36056741Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project.Br J Dermatol2022
35979524Guidance on COVID-19 Vaccination in Hidradenitis Suppurativa Patients: A Modified Delphi Consensus of Experts.Skin Appendage Disord2022
36116584Anakinra for refractory pustular psoriasis: A phase II, open-label, dose-escalation trial.J Am Acad Dermatol2022
33493574Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.J Am Acad Dermatol2022
34990004Medical Management of Hidradenitis Suppurativa with Non-Biologic Therapy: What's New?Am J Clin Dermatol2022
35044423Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa: A Systematic Review.JAMA Dermatol2022
35293815Diagnosing and Managing Hidradenitis Suppurativa in Pediatrics.Pediatr Ann2022
34537252Biologic therapy is not associated with increased COVID-19 severity in patients with hidradenitis suppurativa: Initial findings from the Global Hidradenitis Suppurativa COVID-19 Registry.J Am Acad Dermatol2022
34878495Evaluation of a Case Series of Patients With Palmoplantar Pustulosis in the United States.JAMA Dermatol2022
34878491Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States.JAMA Dermatol2022
36278491Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-α therapy.JCI Insight2022
36056741Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project.Br J Dermatol2022
35979524Guidance on COVID-19 Vaccination in Hidradenitis Suppurativa Patients: A Modified Delphi Consensus of Experts.Skin Appendage Disord2022
36287577Evaluation of Hidradenitis Suppurativa Diagnostic Criteria in Pediatric Patients.JAMA Dermatol2022
36116584Anakinra for refractory pustular psoriasis: A phase II, open-label, dose-escalation trial.J Am Acad Dermatol2022
33493574Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.J Am Acad Dermatol2022
35044423Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa: A Systematic Review.JAMA Dermatol2022
  • 1 - 50 of 184

Recommended Authors

Center for Health and Healing Building 1
Career Start Year 2019
Number of shared co-authors 0
Tufts Medical Center
Career Start Year 2016
Number of shared co-authors 0
Yale University
Career Start Year 2015
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 2015
Number of shared co-authors 1
Yale School of Medicine
Career Start Year 2014
Number of shared co-authors 0
Faculty of Medicine Siriraj Hospital, Mahidol University
Career Start Year 2014
Number of shared co-authors 0
David Geffen School of Medicine, University of California los angeles
Career Start Year 2011
Number of shared co-authors 1
Herlev and Gentofte Hospital, University of Copenhagen
Career Start Year 2011
Number of shared co-authors 0
University of Minnesota
Career Start Year 2010
Number of shared co-authors 0
Loyola University
Career Start Year 2010
Number of shared co-authors 0
University of Kentucky College of Medicine
Career Start Year 2010
Number of shared co-authors 1
University Hospital Quironsalud Madrid
Career Start Year 2009
Number of shared co-authors 0
Medical Subspecialities Institute, Cleveland Clinic
Career Start Year 2008
Number of shared co-authors 0
RTI Health Solutions
Career Start Year 2008
Number of shared co-authors 0
National Pediatrics Institute
Career Start Year 2008
Number of shared co-authors 0
Massachusetts General Hospital, and Harvard Medical School.
Career Start Year 2005
Number of shared co-authors 0
Massachusetts General Hospital, Mass Harvard Medical School
Career Start Year 2005
Number of shared co-authors 0
University of Pennsylvania
Career Start Year 2004
Number of shared co-authors 0
Oregon Health & Science University School of Medicine
Career Start Year 2003
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 2003
Number of shared co-authors 0
Emory University School of Medicine
Career Start Year 2002
Number of shared co-authors 0
NanoString Technologies Inc.
Career Start Year 2002
Number of shared co-authors 2
Oxford University Hospitals NHS Foundation Trust
Career Start Year 1995
Number of shared co-authors 0
Penn State University
Career Start Year 1992
Number of shared co-authors 0
F.I. Proctor Foundation, University of California san francisco
Career Start Year 1992
Number of shared co-authors 0
University of Michigan ann arbor
Career Start Year 1991
Number of shared co-authors 0
University of Cincinnati College of Medicine, and Bernstein Clinical Research Center
Career Start Year 1990
Number of shared co-authors 0
University of Pennsylvania Perelman School of Medicine
Career Start Year 1988
Number of shared co-authors 1
Feinberg School of Medicine, Northwestern University
Career Start Year 1977
Number of shared co-authors 0
University of Toronto
Career Start Year 1976
Number of shared co-authors 0

Collaborators

National Institute of Arthritis and Musculoskeletal and Skin Diseases
Co-authored papers 11
Center for Cancer Research, National Cancer Institute
Co-authored papers 6
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 5
National Cancer Institute, National Institutes of Health
Co-authored papers 5
National Institute of Dental and Craniofacial Research, National Institutes of Health
Co-authored papers 3
Co-authored papers 2
Co-authored papers 2
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1
University of Nebraska Medical Center (UNMC)
Co-authored papers 1
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Co-authored papers 1
Princess Margaret Cancer Centre
Co-authored papers 1
Clinical Center, National Institutes of Health
Co-authored papers 1
National Cancer Institute
Co-authored papers 1
National Cancer Institute
Co-authored papers 1
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 1
Cincinnati Children's Hospital Medical Center
Co-authored papers 1
University of Toronto
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1
Center for Cancer Research, National Cancer Institute.
Co-authored papers 1
National Institute of Dental and Craniofacial Research
Co-authored papers 1
Rutgers Robert Wood Johnson Medical School
Co-authored papers 1
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Co-authored papers 1
University of California Los Angeles
Co-authored papers 1
University of Arkansas for Medical Sciences
Co-authored papers 1
Center for Cellular Engineering, National Institutes of Health Clinical Center
Co-authored papers 1